Skip to contentC
Cumberland Pharmaceuticals Inc
C
CPIXCumberland Pharmaceuticals Inc Q2 2016 · 10-Q
Revenue$7.41M$7.41M−16.8% vs Q2 2015 Net Income-$48.04K-$48.04KN/M vs Q2 2015 EPS Diluted$0.00$0.00−100.0% vs Q2 2015 Operating Income-$105,309N/M Operating Cash Flow
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Cumberland Pharmaceuticals Inc · CIK 1087294 · Engraved from SEC EDGAR
derived
Free Cash Flowderived-$1,139,820N/M Margins · derivedOperating margin-1.4%−9.0 pt vs Q2 2015
Net margin-0.6%−5.2 pt vs Q2 2015
ended Jun 30, 2016 · filed Aug 5, 2016 · 36 d after period end